Authors



MSPharm, RPH, CACP

Latest:

Hemostasis and Thrombosis Issues

News in the world of anticoagulation is presented, including insights on the new guidelines for warfarin.


Roni Shiloh, MD

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Curtis D. Greenwood, Esq

Latest:

Landmark Supreme Court Ruling: State Regulation of PBM Reimbursement Rates

Supreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.


Sarah Lee, PharmD, MS

Latest:

340B and the Medicare Cost Report

Certain institutional providers are required to file a Medicare cost report annually to CMS, which uses that information to set prospective payment rates and determine if Medicare overpaid or underpaid a given institution during the submitted fiscal year.


Titilope Adeniyi, MS

Latest:

Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and Outcomes

This study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.


Brian G. Cochran, PharmD, BCOP

Latest:

Evolutions in Outpatient Cancer Care

Within the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.


John Fastenau, MPH, RPh

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Aleda M. H. Chen, PharmD, PhD, FAPhA

Latest:

Addressing Vaccine Hesitancy Among Health Care Workers

Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.



Evan Colmenares, PHarmD

Latest:

Data Aggregation in Specialty Pharmacy

The value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.


Niteesh K. Choudhry, MD, PhD

Latest:

Comparative Effectiveness Research: Is "Synchronicity" a Valid Outcome?

Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.


Jacob T. Painter, PharmD, MBA, PhD

Latest:

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome

While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.



Mei Sheng Duh, MPH, ScD

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Rae L. Bourne, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Brian Dickerson

Latest:

Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims Allegations

Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.


Christine Roussel, PharmD, BCOP

Latest:

Highlighting the Risk of Occupational Exposure to Hazardous Drugs in the Health Care Setting

The health care setting has the largest and most diverse array of agents that are hazardous to humans.


Theresa Wokuluk

Latest:

Taking Care of Transplant Patients: A Look at ModernHEALTH

Once patients receive their new organs, the specialty pharmacy can help them navigate through lifelong, complex transplant therapy. Here's a look at one such program.



Aylin Altan, PhD

Latest:

Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs

The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.



Marilyn Bulloch, PharmD, BCPS

Latest:

Understand the 2025-2026 Flu Vaccine Composition Recommendations

The only major change is in the included strain of influenza A/H2N2 virus, which has been updated for both the egg-based and the cell- and recombinant-based vaccines.





Gunda Siska

Latest:

The Beauty of Vitamin A and Drug Spinoffs

The best natural and dietary supplements get turned into drugs. This is what happened to Vitamin A.


Muzi Hua, PharmD Candidate

Latest:

Study Examines Impact of Alcohol on Health, Drug Interactions in Older Women

Five risk factors increased the likelihood of problematic alcohol consumption in older women.


Dhiren Patel, PharmD, CDE, BC-ADM, BCACP

Latest:

Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should Know

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.